Benjamin Edwards’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$746K Sell
17,103
-30,355
-64% -$1.41M 0.01% 918
2026
Q2
$2.03M Buy
47,458
+2,263
+5% +$123K 0.02% 567
2026
Q1
$2.84M Buy
45,195
+26,690
+144% +$2.14M 0.03% 455
2025
Q4
$1.76M Buy
18,505
+79
+0.4% +$7.74K 0.02% 549
2025
Q3
$1.8M Buy
18,426
+670
+4% +$69.4K 0.02% 514
2025
Q2
$1.91M Buy
17,756
+1,958
+12% +$198K 0.02% 467
2025
Q1
$1.59M Buy
15,798
+815
+5% +$82.1K 0.02% 472
2024
Q4
$1.34M Buy
14,983
+829
+6% +$73K 0.02% 529
2024
Q3
$1.19M Buy
14,154
+13,880
+5,066% +$1.09M 0.02% 550
2024
Q2
$21K Buy
274
+93
+51% +$6.81K ﹤0.01% 583
2024
Q1
$12K Buy
+181
New +$11.6K ﹤0.01% 624

Other funds holding BSX

Benjamin Edwards's BSX Position: Q3 2026 in Review

Benjamin Edwards reduced its Boston Scientific (BSX) stake by 64% in Q3 2026, selling an estimated $1.41M and leaving 17,103 shares worth $746K. The position accounts for 0.01% of the portfolio, ranked #918.

Benjamin Edwards first reported a position in BSX in Q1 2024 and has held it in 11 quarters since. The position peaked at $2.84M in Q1 2026. 1,274 funds tracked by Wall St. Rank hold BSX as of Q3 2026.

  • Benjamin Edwards held 17,103 shares of Boston Scientific worth $746K as of Q3 2026.
  • Benjamin Edwards sold 30,355 Boston Scientific shares in Q3 2026, an estimated $1.41M.
  • Boston Scientific made up 0.01% of Benjamin Edwards's portfolio in Q3 2026, its #918 holding.
  • Benjamin Edwards first reported a position in Boston Scientific in Q1 2024 and has held it in 11 quarters since.
  • Benjamin Edwards's Boston Scientific position peaked at $2.84M in Q1 2026.
  • 1,274 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2026.

Based on Benjamin Edwards's 13F filing for Q3 2026, filed 12 Nov 2026.